Publication | Closed Access

Folic acid-appended galactoxyloglucan-capped iron oxide nanoparticles as a biocompatible nanotheranostic agent for tumor-targeted delivery of doxorubicin

NanoparticlesNanomedicineBiocompatible Nanotheranostic AgentNanotherapeuticsEngineeringTherapeutic NanomaterialsMedicinePharmaceutical NanotechnologyNano-drug DeliveryTumor TargetingBiomedical EngineeringPharmacologyTumor-targeted Delivery